当前位置: X-MOL 学术Clin. Neurol. Neurosurg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Post-operative hyperglycemia and its association with surgical site infection after instrumented spinal fusion
Clinical Neurology and Neurosurgery ( IF 1.8 ) Pub Date : 2020-10-01 , DOI: 10.1016/j.clineuro.2020.106100
Shivam Upadhyaya 1 , Wylie Y Lopez 1 , Brian C Goh 1 , Antonia F Chen 1 , Justin A Blucher 1 , Aaron Beck 1 , James D Kang 1 , Andrew J Schoenfeld 1
Affiliation  

OBJECTIVE To evaluate the correlation between postoperative hyperglycemia and surgical site infection among patients who underwent primary instrumented spinal fusion surgery. PATIENTS AND METHODS We collected data on all eligible patients treated at our institution over the course of 2005-2017. We defined serum hyperglycemia using a primary threshold of serum glucose ≥140 mg/dL and used ≥115 mg/dL as a secondary test. We used logistic regression techniques to evaluate unadjusted results for serum hyperglycemia on revision surgeries for infection, followed by sequential adjustment for sociodemographic and procedural characteristics. RESULTS We included 3664 patients. Surgical site infections occurred in 4%. Post-operative hyperglycemia was significantly associated with a higher rate of revision surgery for infection (p = 0.02). Following adjusted analysis, hyperglycemia remained a statistically significant predictor for revision surgery due to infection (OR 2.19; 95 % CI 1.13, 4.25). Similar results were evident when using the lower threshold of ≥115 mg/dL (OR 2.36; 95 % CI 1.06, 5.23). CONCLUSIONS This study highlights the importance of measuring serum glucose after spinal fusion and the need for heightened surveillance and/or treatment in those who exhibit postoperative hyperglycemia. In this context, it could be advantageous to use a lower threshold for hyperglycemia (115 mg/dL) in order to trigger interventions for glycemic control.

中文翻译:

脊柱融合术后高血糖及其与手术部位感染的关系

目的 评价初次脊柱融合手术患者术后高血糖与手术部位感染的相关性。患者和方法 我们收集了 2005-2017 年期间在我们机构接受治疗的所有符合条件的患者的数据。我们使用血清葡萄糖 ≥ 140 mg/dL 的主要阈值定义血清高血糖,并使用≥115 mg/dL 作为次要测试。我们使用逻辑回归技术评估感染修复手术中未调整的血清高血糖结果,然后对社会人口学和手术特征进行顺序调整。结果 我们纳入了 3664 名患者。手术部位感染发生率为 4%。术后高血糖与较高的感染修正手术率显着相关(p = 0.02)。经过调整分析,高血糖仍然是感染引起的翻修手术的统计学显着预测因子(OR 2.19;95 % CI 1.13, 4.25)。当使用 ≥ 115 mg/dL 的下限时,类似的结果很明显(OR 2.36;95 % CI 1.06, 5.23)。结论 本研究强调了在脊柱融合术后测量血清葡萄糖的重要性,以及对出现术后高血糖的患者加强监测和/或治疗的必要性。在这种情况下,使用较低的高血糖阈值 (115 mg/dL) 以触发血糖控制干预可能是有利的。23)。结论 本研究强调了在脊柱融合术后测量血清葡萄糖的重要性,以及对出现术后高血糖的患者加强监测和/或治疗的必要性。在这种情况下,使用较低的高血糖阈值 (115 mg/dL) 以触发血糖控制干预可能是有利的。23)。结论 本研究强调了在脊柱融合术后测量血清葡萄糖的重要性,以及对出现术后高血糖的患者加强监测和/或治疗的必要性。在这种情况下,使用较低的高血糖阈值 (115 mg/dL) 以触发血糖控制干预可能是有利的。
更新日期:2020-10-01
down
wechat
bug